UR CTSI Coordinates Coronavirus Research to Maximize Impact

When COVID-19 first hit Rochester, a team of clinicians and researchers – led by the UR CTSI - mobilized to bring the most promising clinical trials to URMC. Since then, UR CTSI has been pivotal in helping researchers quickly adapt and refocus to meet the challenge of the global COVID-19 pandemic.

COVID-19 Biobank Helps Researchers Share Patients’ Samples

The dedicated biorepository will safely collect and store serum, plasma and immune cell samples from COVID-19-positive and -negative patients. Researchers will be able to request access to the samples, which will be linked to the patients’ de-identified clinical data.

Facing the Future: Team Science and Funding for Coronavirus Research

URMC investigators who are pursuing COVID-19-related grants are encouraged to participate in a series of virtual team science sessions, taking place May 11-14, to identify and discuss opportunities for funding and synergy and to receive feedback on applications.

Just a Drop of Blood: An Easier Way to Test for COVID-19

UR CTSI Co-Director Martin Zand, M.D., Ph.D., is rapidly adapting previous flu research to develop a potential diagnostic test that would require just a few drops of blood to detect COVID-19 immunity.

Engaging Patients in Person Nearly Triples Research Registry Enrollment

Participant recruitment is a major challenge for clinical research, but a recent pilot study showed that the Emergency Department Research Associate Program nearly tripled enrollment in the university’s clinical research registry.